Scroll To Top

biktarvy

Friends at a cafe
Treatment

The FDA Says This Group Can Now Use Biktarvy Safely

The once-daily regimen for those with HIV can now be prescribed to those with a common treatment resistance.

Two young men sitting outside near the water
Treatment

New Research Shows Long-Acting Injectable is Preferable to Pills

Ninety percent of study participants preferred the every-two-month HIV treatment regimen over taking a daily pill.